Scott A Hollingsworth

11PUBLICATIONS
39CO-AUTHORS
PharmacogenomicsTraditional Chinese medicine and treatmentsGlycoconjugatesMolecular targetsReaction engineering (excl. nuclear reactions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 14, 2026
Discovery of Biased Dual-Agonists of Glucagon-Like Peptide 1 and Glucagon Receptors through Mutation of a Conserved Aspartate.

|Jan 07, 2026
Discovery of IID432 for Chagas Disease: A Cyanotriazole Inhibitor of Trypanosoma cruzi Topoisomerase II Achieves Sterile Cure After Short-Term Treatment in a Chronic Infection Model.

Olivier René, Manuel Saldivia, Maxime Dauphinais

|Apr 29, 2025
Antibody-Drug Conjugates of NLRP3 Agonists: How Overcoming Lysosomal Accumulation Necessitated Noncanonical Linker Attachments.

Paul S Riehl, Meng Yao Zhang, Payal Dhar

|Aug 22, 2024
Design and Optimization of Selectivity-Tunable Toll-like Receptor 7/8 Agonists as Novel Antibody-Drug Conjugate Payloads.

Akash M Patel, Aarron Willingham, Alan C Cheng

|Jan 23, 2024
Author Correction: Functionally selective signaling and broad metabolic benefits by novel insulin receptor partial agonists.

Margaret Wu, Ester Carballo-Jane, Haihong Zhou

|Mar 17, 2022
Discovery of Insulin Receptor Partial Agonists MK-5160 and MK-1092 as Novel Basal Insulins with Potential to Improve Therapeutic Index.

Dmitri A Pissarnitski, Ahmet Kekec, Lin Yan

Pageof 2

Frequent Collaborators

3 joint publications

Ron O Dror

2 joint publications

W Michael Seganish

2 joint publications

James Mu

2 joint publications

Haihong Zhou